0.9232  0.022 (2.45%)		09-13 16:00
Open: 0.9011 High: 0.96 Volume: 442,653		Pre. Close: 0.9011 Low: 0.8688 Market Cap: 131(M)

Short term
Mid term
Targets	6-month :	1.13	1-year :	1.26
Resists	First :	0.96	Second :	1.08
Pivot price	0.93
Supports	First :	0.79	Second :	0.65
MAs	MA(5) :	0.92	MA(20) :	0.94
	MA(100) :	1.25	MA(250) :	1.49
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	21.4	D(3) :	25.9
RSI	RSI(14): 46.8
52-week	High :	2.43	Low :	0.73

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ QSI ] has closed above bottom band by 37.7%. Bollinger Bands are 67.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 11 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	0.96 - 0.97	0.97 - 0.97
Low:	0.86 - 0.86	0.86 - 0.87
Close:	0.91 - 0.92	0.92 - 0.93

Quantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing. It offers a proprietary single molecule detection platform for use in semiconductor industry to field proteomics to enable next generation protein sequencing. The company was incorporated in 2013 is based in Guilford, Connecticut.

Thu, 12 Sep 2024
Quantum-Si (NASDAQ:QSI) Trading Down 2.4% - MarketBeat

Fri, 06 Sep 2024
QuantumSi Incorporated (QSI) Upgraded to Buy: What Does It Mean for the Stock? - MSN

Wed, 04 Sep 2024
Liberate Bio Integrates Quantum-Si’s Next-Generation Protein Sequencing™ Platform to Enhance Gene Therapy Development - Business Wire

Tue, 27 Aug 2024
CORRECTING and REPLACING Quantum-Si Announces New Executive Team Members to Accelerate the Evolution of the Company into a Leading Proteomic Tool Provider - Business Wire

Tue, 27 Aug 2024
Quantum-Si Announces New Executive Team Members to Accelerate the Evolution of the Company into a Leading Proteomic Tool Provider - StockTitan

Mon, 26 Aug 2024
Quantum-Si to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - Yahoo Finance

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	0 (M)
Shares Float	122 (M)
Held by Insiders	1.0194e+008 (%)
Held by Institutions	19.4 (%)
Shares Short	6,400 (K)
Shares Short P.Month	0 (K)

EPS	-9.552e+007
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	-4 %
Return on Assets (ttm)	252.5 %
Return on Equity (ttm)	-21 %
Qtrly Rev. Growth	1.7e+006 %
Gross Profit (p.s.)	69.65
Sales Per Share	-11.16
EBITDA (p.s.)	0
Qtrly Earnings Growth	-0.7 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	-84 (M)

PE Ratio	-0.01
PEG Ratio	0
Price to Book value	0
Price to Sales	-0.09
Price to Cash Flow	1.64

Dividend	0
Forward Dividend	5.85e+006
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.